Athena Global Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 11:09 pm

Quick Insight

Athena Global Technologies Ltd's current share price of 97.0 indicates an undervaluation with a Price-to-Book Value ratio of 0.70x. However, the negative Operating Profit Margin of -144.98% and an Interest Coverage Ratio of -0.54x raise concerns about the company's financial health. The Return on Equity at 10.6% and Return on Capital Employed at 2.59% suggest average profitability and capital utilization efficiency. With Promoters holding a significant stake at 61.44% and Reserves standing at 166 Cr., there is a solid foundation for growth. Yet, the negative Net Profit of -20 Cr. and Borrowings of ₹89 Cr. demand a closer look at the company's operational performance and debt management strategies for sustainable growth.

Competitors of Athena Global Technologies Ltd

All Competitor Stocks of Athena Global Technologies Ltd

Quarterly Result

Last Updated: August 19, 2025, 11:05 pm

Below is a detailed analysis of the quarterly data for Athena Global Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3.02 Cr.. The value appears strong and on an upward trend. It has increased from 2.89 Cr. (Mar 2025) to 3.02 Cr., marking an increase of 0.13 Cr..
• For Expenses, as of Jun 2025, the value is 4.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.08 Cr. (Mar 2025) to 4.41 Cr., marking a decrease of 2.67 Cr..
• For Operating Profit, as of Jun 2025, the value is -1.39 Cr.. The value appears strong and on an upward trend. It has increased from -4.19 Cr. (Mar 2025) to -1.39 Cr., marking an increase of 2.80 Cr..
• For OPM %, as of Jun 2025, the value is -46.03%. The value appears strong and on an upward trend. It has increased from -144.98% (Mar 2025) to -46.03%, marking an increase of 98.95%.
• For Other Income, as of Jun 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.45 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.43 Cr..
• For Interest, as of Jun 2025, the value is 2.63 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.90 Cr. (Mar 2025) to 2.63 Cr., marking a decrease of 0.27 Cr..
• For Depreciation, as of Jun 2025, the value is 0.35 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.35 Cr..
• For Profit before tax, as of Jun 2025, the value is -4.35 Cr.. The value appears strong and on an upward trend. It has increased from -6.99 Cr. (Mar 2025) to -4.35 Cr., marking an increase of 2.64 Cr..
• For Tax %, as of Jun 2025, the value is -0.23%. The value appears to be increasing, which may not be favorable. It has increased from -1.72% (Mar 2025) to -0.23%, marking an increase of 1.49%.
• For Net Profit, as of Jun 2025, the value is -4.34 Cr.. The value appears strong and on an upward trend. It has increased from -6.88 Cr. (Mar 2025) to -4.34 Cr., marking an increase of 2.54 Cr..
• For EPS in Rs, as of Jun 2025, the value is -3.09. The value appears strong and on an upward trend. It has increased from -4.90 (Mar 2025) to -3.09, marking an increase of 1.81.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:47 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:48 pm

Below is a detailed analysis of the balance sheet data for Athena Global Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 166.00 Cr.. The value appears to be declining and may need further review. It has decreased from 186.00 Cr. (Mar 2024) to 166.00 Cr., marking a decrease of 20.00 Cr..
• For Borrowings, as of Mar 2025, the value is 89.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 86.00 Cr. (Mar 2024) to 89.00 Cr., marking an increase of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 73.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 39.00 Cr. (Mar 2024) to 73.00 Cr., marking an increase of 34.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 342.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 325.00 Cr. (Mar 2024) to 342.00 Cr., marking an increase of 17.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 322.00 Cr.. The value appears strong and on an upward trend. It has increased from 273.00 Cr. (Mar 2024) to 322.00 Cr., marking an increase of 49.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 32.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 32.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 3.00 Cr..
• For Other Assets, as of Mar 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 21.00 Cr., marking an increase of 4.00 Cr..
• For Total Assets, as of Mar 2025, the value is 342.00 Cr.. The value appears strong and on an upward trend. It has increased from 325.00 Cr. (Mar 2024) to 342.00 Cr., marking an increase of 17.00 Cr..

Notably, the Reserves (166.00 Cr.) exceed the Borrowings (89.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Athena Global Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -15.06. This value is below the healthy minimum of 5. It has decreased from 153.29 (Mar 24) to -15.06, marking a decrease of 168.35.
• For Diluted EPS (Rs.), as of Mar 25, the value is -13.12. This value is below the healthy minimum of 5. It has decreased from 146.19 (Mar 24) to -13.12, marking a decrease of 159.31.
• For Cash EPS (Rs.), as of Mar 25, the value is -13.90. This value is below the healthy minimum of 3. It has decreased from 146.12 (Mar 24) to -13.90, marking a decrease of 160.02.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 128.23. It has decreased from 142.02 (Mar 24) to 128.23, marking a decrease of 13.79.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 128.23. It has decreased from 142.02 (Mar 24) to 128.23, marking a decrease of 13.79.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 11.12. It has increased from 9.80 (Mar 24) to 11.12, marking an increase of 1.32.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -4.68. This value is below the healthy minimum of 2. It has decreased from 153.91 (Mar 24) to -4.68, marking a decrease of 158.59.
• For PBIT / Share (Rs.), as of Mar 25, the value is -5.11. This value is below the healthy minimum of 0. It has decreased from 153.68 (Mar 24) to -5.11, marking a decrease of 158.79.
• For PBT / Share (Rs.), as of Mar 25, the value is -13.68. This value is below the healthy minimum of 0. It has decreased from 146.41 (Mar 24) to -13.68, marking a decrease of 160.09.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -14.34. This value is below the healthy minimum of 2. It has decreased from 145.90 (Mar 24) to -14.34, marking a decrease of 160.24.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -14.34. This value is below the healthy minimum of 2. It has decreased from 146.35 (Mar 24) to -14.34, marking a decrease of 160.69.
• For PBDIT Margin (%), as of Mar 25, the value is -42.05. This value is below the healthy minimum of 10. It has decreased from 1,569.64 (Mar 24) to -42.05, marking a decrease of 1,611.69.
• For PBIT Margin (%), as of Mar 25, the value is -45.96. This value is below the healthy minimum of 10. It has decreased from 1,567.37 (Mar 24) to -45.96, marking a decrease of 1,613.33.
• For PBT Margin (%), as of Mar 25, the value is -123.05. This value is below the healthy minimum of 10. It has decreased from 1,493.17 (Mar 24) to -123.05, marking a decrease of 1,616.22.
• For Net Profit Margin (%), as of Mar 25, the value is -128.92. This value is below the healthy minimum of 5. It has decreased from 1,487.96 (Mar 24) to -128.92, marking a decrease of 1,616.88.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -128.92. This value is below the healthy minimum of 8. It has decreased from 1,492.55 (Mar 24) to -128.92, marking a decrease of 1,621.47.
• For Return on Networth / Equity (%), as of Mar 25, the value is -11.18. This value is below the healthy minimum of 15. It has decreased from 102.79 (Mar 24) to -11.18, marking a decrease of 113.97.
• For Return on Capital Employeed (%), as of Mar 25, the value is -2.78. This value is below the healthy minimum of 10. It has decreased from 79.25 (Mar 24) to -2.78, marking a decrease of 82.03.
• For Return On Assets (%), as of Mar 25, the value is -5.88. This value is below the healthy minimum of 5. It has decreased from 63.26 (Mar 24) to -5.88, marking a decrease of 69.14.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has decreased from 0.28 (Mar 24) to 0.26, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.49. This value is within the healthy range. It has increased from 0.33 (Mar 24) to 0.49, marking an increase of 0.16.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.04. It has decreased from 0.06 (Mar 24) to 0.04, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1.5. It has decreased from 0.30 (Mar 24) to 0.23, marking a decrease of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has decreased from 0.30 (Mar 24) to 0.23, marking a decrease of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 326.00. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 326.00, marking an increase of 326.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 3. It has decreased from 21.16 (Mar 24) to -0.54, marking a decrease of 21.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.67. This value is below the healthy minimum of 3. It has decreased from 21.05 (Mar 24) to -0.67, marking a decrease of 21.72.
• For Enterprise Value (Cr.), as of Mar 25, the value is 215.08. It has increased from 193.33 (Mar 24) to 215.08, marking an increase of 21.75.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 13.77. This value exceeds the healthy maximum of 3. It has decreased from 14.03 (Mar 24) to 13.77, marking a decrease of 0.26.
• For EV / EBITDA (X), as of Mar 25, the value is -32.73. This value is below the healthy minimum of 5. It has decreased from 0.89 (Mar 24) to -32.73, marking a decrease of 33.62.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.17. This value exceeds the healthy maximum of 3. It has decreased from 9.18 (Mar 24) to 8.17, marking a decrease of 1.01.
• For Price / BV (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.70, marking an increase of 0.07.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.17. This value exceeds the healthy maximum of 3. It has decreased from 9.18 (Mar 24) to 8.17, marking a decrease of 1.01.
• For EarningsYield, as of Mar 25, the value is -0.15. This value is below the healthy minimum of 5. It has decreased from 1.63 (Mar 24) to -0.15, marking a decrease of 1.78.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness